Physicians' evaluation of clinical pharmacy revealed increased focus on quality improvement and cost savings

被引:0
|
作者
Kjeldsen, Lene Juel [1 ]
Jensen, Trine Bjerregaard [1 ]
Jensen, Jens Jorn [1 ]
机构
[1] Amgros IS, SAFE, DK-2100 Copenhagen O, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
INTRODUCTION: The aims of the present study were to evaluate physicians' satisfaction with medication services delivered by a clinical pharmacist (CP); to investigate and document to which extent a CP could improve the medication quality and reduce medication costs at an intensive care unit (ICU); and to explore which types of tasks the CP was asked to perform. MATERIAL AND METHODS: The project was conducted at an ICU from 1 February to 31 August 2008. The intervention consisted of certain tasks being performed by a CP. The intervention was evaluated on the basis of documentation of the intervention performed and on a questionnaire filled in by physicians at the end of the study. RESULTS: The majority of the physicians reported that the CP's intervention had raised their attention to medication costs (70%) and medication quality (76%). This physician-reported impression correlated with the CP's intervention which improved medication quality and catalysed an annual estimated cost saving of at least DKK 330,000, which was achieved by targeting particular medication areas. The CP was asked to perform various medication-related tasks during the project period. Indeed, the physicians reported that they found the CP qualified to perform several medication-related tasks -and many physicians reported that they had benefitted from input regarding those tasks. CONCLUSION: The intervention occasioned positive physician feedback on clinical pharmacy services and the study shows that the CP was perceived by the physicians as a valuable professional collaborator.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] Re: Value-Based Insurance Design: Quality Improvement but No Cost Savings Editorial Comment
    Penson, David F.
    JOURNAL OF UROLOGY, 2014, 191 (03): : 761 - 762
  • [32] Evaluation and improvement of the microbiological quality of the antiseptics prepared at the pharmacy of the Rabat Specialties Hospital
    Derfoufi, S.
    Seffar, M.
    El Kadi, M. A.
    Lmimouni, B. E.
    El Mellouki, W.
    Bensouda, Y.
    ANTIBIOTIQUES, 2009, 11 (03): : 171 - 176
  • [33] COST-EVALUATION MODEL FOR CLINICAL-TRIALS IN A HOSPITAL PHARMACY SERVICE
    IDOATE, A
    ORTEGA, A
    CARRERA, FJ
    ALDAZ, A
    GIRALDEZ, J
    PHARMACY WORLD & SCIENCE, 1995, 17 (05): : 172 - 176
  • [34] Potential cost savings of a continuous quality improvement (CQI) program as part of an oncology medical home.
    Winn, Daniel
    Wong, Winston
    Cooper, Joseph
    Olson, Tim
    Trehan, Ram Swarup
    Scott, Jeffrey A.
    Feinberg, Bruce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Home bowel preparation for elective colonic procedures in children: Cost savings with quality assurance and improvement - Discussion
    Nicolette, LA
    Carter, ME
    Seashore, JH
    JOURNAL OF PEDIATRIC SURGERY, 2000, 35 (02) : 234 - 234
  • [36] Mechanical induction of labour (MIOL) for all multips in a tertiary unit: A quality improvement project with cost savings
    Maxey, V
    Harlow, F.
    Maina, W.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 125 : 33 - 33
  • [37] REDUCTION IN USE OF CONSTANT OBSERVATION IN THE GENERAL-HOSPITAL AND COST SAVINGS AS A RESULT OF QUALITY IMPROVEMENT MONITORING
    ODOWD, MA
    FREEDMAN, JB
    BERNSTEIN, G
    RICCO, P
    MCKEGNEY, FP
    PSYCHOSOMATICS, 1995, 36 (02) : 189 - 189
  • [38] CONTINUOUS IMPROVEMENT, QUALITY-CONTROL, AND COST-CONTAINMENT IN CLINICAL LABORATORY TESTING - ENHANCEMENT OF PHYSICIANS LABORATORY-ORDERING PRACTICES
    NARDELLA, A
    FARRELL, M
    PECHET, L
    SNYDER, LM
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1994, 118 (10) : 965 - 968
  • [39] Evaluation of an integrated workers' compensation/health insurance pharmacy benefit program: Satisfaction, health outcomes,and potential cost savings
    Saleh, SS
    Washington, S
    Stapleton, D
    Livermore, G
    VALUE IN HEALTH, 2003, 6 (03) : 214 - 214
  • [40] Evaluation of drug cost savings related to clinical trials from the perspective of a university hospital
    Perrier, Quentin
    Minoves, Melanie
    Cerana, Sophie
    Reymond, Fabienne
    Ducki, Camille
    Decaens, Thomas
    Lehmann, Audrey
    Bedouch, Pierrick
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024, 31 (06) : 520 - 525